Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LENZ Therapeutics (LENZ) Interest & Investment Income (2023 - 2025)

LENZ Therapeutics (LENZ) has disclosed Interest & Investment Income for 1 consecutive years, with $851000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Interest & Investment Income changed N/A to $851000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $2.2 million, a N/A change, with the full-year FY2024 number at $8.6 million, up 290.73% from a year prior.
  • Interest & Investment Income was $851000.0 for Q4 2023 at LENZ Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q3 2023 to a low of $251000.0 in Q2 2023.